The FDA has placed another clinical hold on a gene therapy for Duchenne muscular dystrophy developed by Solid Biosciences, pulverising its share price. The halt of the IGNITE DMD trial was prompted by ...
As my tiny boat sailed into the equally tiny port of the city-state of Portia, I couldn't help but look beyond the small town and toward a decrepit tower looming over its peaceful villagers; I wanted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback